Search Results - "Wass, Romana"

Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature by Leitinger, Markus, Varosanec, Mihael V, Pikija, Slaven, Wass, Romana E, Bandke, Dave, Weis, Serge, Studnicka, Michael, Grinzinger, Susanne, McCoy, Mark R, Hauer, Larissa, Sellner, Johann

“…Immune checkpoint inhibitors are antibodies, which enhance cellular and humoral immune responses and are approved for the treatment of various tumors…”
Get full text

First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes by Lang, David, Ritzberger, Linda, Rambousek, Vanessa, Horner, Andreas, Wass, Romana, Akbari, Kaveh, Kaiser, Bernhard, Kronbichler, Jürgen, Lamprecht, Bernd, Gabriel, Michael

“…Quantitative biomarkers derived from positron-emission tomography/computed tomography (PET/CT) have been suggested as prognostic variables in immune-checkpoint…”
Get full text

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis by Hochmair, Maximilian J., Fabikan, Hannah, Illini, Oliver, Weinlinger, Christoph, Setinek, Ulrike, Krenbek, Dagmar, Prosch, Helmut, Rauter, Markus, Schumacher, Michael, Wöll, Ewald, Wass, Romana, Brehm, Elmar, Absenger, Gudrun, Bundalo, Tatjana, Errhalt, Peter, Urban, Matthias, Valipour, Arschang

“…In clinical practice, patients with anaplastic lymphoma kinase (ALK)-rearrangement–positive non–small-cell lung cancer commonly receive sequential treatment…”
Get full text

Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis by Grambozov, Brane, Nussdorfer, Evelyn, Kaiser, Julia, Gerum, Sabine, Fastner, Gerd, Stana, Markus, Gaisberger, Christoph, Wass, Romana, Studnicka, Michael, Sedlmayer, Felix, Zehentmayr, Franz

“…The treatment of locally recurrent lung cancer is a major challenge for radiation-oncologists, especially with data on high-dose reirradiation being limited to…”
Get full text

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study by Lang, David, Huemer, Florian, Rinnerthaler, Gabriel, Horner, Andreas, Wass, Romana, Brehm, Elmar, Akbari, Kaveh, Granitz, Marcel, Hutarew, Georg, Kaiser, Bernhard, Greil, Richard, Lamprecht, Bernd

“…Background Evidence on PD-1/PD-L1-directed immune checkpoint inhibitor (ICI) therapy for advanced non-small-cell lung cancer (NSCLC) is mainly based on…”
Get full text

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis by Grambozov, Brane, Wass, Romana, Stana, Markus, Gerum, Sabine, Karner, Josef, Fastner, Gerd, Studnicka, Michael, Sedlmayer, Felix, Zehentmayr, Franz

“…Background Given the limited curative treatment options for recurrent lung cancer patients, the aim of our retrospective study was to investigate whether these…”
Get full text

Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer by Grambozov, Brane, Wolf, Frank, Kaiser, Julia, Wass, Romana, Fastner, Gerd, Gaisberger, Christoph, Rettenbacher, Lukas, Studnicka, Michael, Pirich, Christian, Sedlmayer, Felix, Zehentmayr, Franz

“…Background Chemoradiotherapy (CRT) is the standard treatment for patients with inoperable stage III non‐small cell lung cancer (NSCLC) stage III. With a median…”
Get full text

Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation by Zehentmayr, Franz, Sprenger, Martin, Rettenbacher, Lukas, Wass, Romana, Porsch, Peter, Fastner, Gerd, Pirich, Christian, Studnicka, Michael, Sedlmayer, Felix

“…Background Approximately 15% of lung cancer patients are diagnosed in early stages. Microscopic proof of disease cannot always be obtained because of…”
Get full text

Antibody–drug conjugates (ADCs) in lung cancer treatment by Wass, Romana E., Lang, David, Horner, Andreas, Lamprecht, Bernd

“…Summary ADCs will likely become another important treatment strategy in advanced, pretreated lung cancer where current treatment options are limited. Both…”
Get full text

(Neo)adjuvant approaches in lung cancer—paving the road to a cure by Wass, Romana, Hochmair, Maximilian, Lang, David, Horner, Andreas, Lamprecht, Bernd

“…Summary Immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape of metastatic non-small-cell lung cancer (NSCLC). During the past few…”
Get full text

Checkpoint inhibitor pneumonitis: Short review of literature and case report by Wass, Romana Elisabeth, Lang, David, Horner, Andreas, Lamprecht, Bernd

“…Summary Immune checkpoint blockade (ICB) has fundamentally improved the treatment landscape of advanced lung cancer. Improved tolerability and encouraging…”
Get full text

Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study by Lang, David, Brauner, Anna, Huemer, Florian, Rinnerthaler, Gabriel, Horner, Andreas, Wass, Romana, Brehm, Elmar, Kaiser, Bernhard, Greil, Richard, Lamprecht, Bernd

“…Men with non-small cell lung cancer (NSCLC) have a more favorable response to immune-checkpoint inhibitor (ICI) monotherapy, while women especially benefit…”
Get full text

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity by Wass, Romana, Hochmair, Maximilian, Kaiser, Bernhard, Grambozov, Brane, Feurstein, Petra, Weiß, Gertraud, Moosbrugger, Raphaela, Sedlmayer, Felix, Lamprecht, Bernd, Studnicka, Michael, Zehentmayr, Franz

“…Introduction: The standard of care (SoC) for unresectable stage III non-small-cell lung cancer (NSCLC) is durvalumab maintenance therapy after concurrent…”
Get full text

Targeted therapy in lung cancer—ASCO 2019 update by Wass, Romana E., Lang, David, Lamprecht, Bernd, Studnicka, Michael

“…Summary New targeted therapies for patients with non small cell lung cancer were presented at this year’s ASCO. EGFR exon 20 insertions might soon be treatable…”
Get full text

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Retrospective Comparison Focusing on Pulmonary Toxicity by Wass, Romana, Hochmair, Maximilian, Kaiser, Bernhard, Grambozov, Brane, Feurstein, Petra, Weiß, Gertraud, Moosbrugger, Raphaela, Sedlmayer, Felix, Lamprecht, Bernd, Studnicka, Michael, Zehentmayr, Franz

“…Introduction: The standard of care (SoC) for unresectable stage III non-small-cell lung cancer (NSCLC) is durvalumab maintenance therapy after concurrent…”
Get full text

Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria by Studnicka, Michael, Baumgartner, Bernhard, Bolitschek, Josef, Doberer, Daniel, Eber, Ernst, Eckmayr, Josef, Hartl, Sylvia, Hesse, Peter, Jaksch, Peter, Kink, Eveline, Kneussl, Meinhard, Lamprecht, Bernd, Olschewski, Horst, Pfleger, Andreas, Pohl, Wolfgang, Prior, Christian, Puelacher, Christoph, Renner, Andreas, Steflitsch, Wolfgang, Stelzmüller, Ingrid, Täubl, Helmut, Vonbank, Karin, Wagner, Marlies, Wantke, Felix, Wass, Romana

Get full text

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study by Lang, David, Haslinger, Wolfgang, Akbari, Kaveh, Scala, Mario, Hergan, Benedikt, Asel, Christian, Horner, Andreas, Wass, Romana, Brehm, Elmar, Kaiser, Bernhard, Lamprecht, Bernd

“…To evaluate serum tumor markers (STM) as predictive biomarkers in advanced non-small cell lung cancer (NSCLC) treated with chemo-immunotherapy. Patients having…”
Get full text

Masterplan 2025 der Österreichischen Gesellschaft für Pneumologie (ÖGP) – die erwartete Entwicklung und Versorgung respiratorischer Erkrankungen in Österreich by Studnicka, Michael, Baumgartner, Bernhard, Bolitschek, Josef, Doberer, Daniel, Eber, Ernst, Eckmayr, Josef, Hartl, Sylvia, Hesse, Peter, Jaksch, Peter, Kink, Eveline, Kneussl, Meinhard, Lamprecht, Bernd, Olschewski, Horst, Pfleger, Andreas, Pohl, Wolfgang, Prior, Christian, Puelacher, Christoph, Renner, Andreas, Steflitsch, Wolfgang, Stelzmüller, Ingrid, Täubl, Helmut, Vonbank, Karin, Wagner, Marlies, Wantke, Felix, Wass, Romana

“…Zusammenfassung Mitglieder der Österreichischen Gesellschaft für Pneumologie (ÖGP) beschreiben die erwartete Entwicklung der respiratorischen Gesundheit und…”
Get full text